성분 사전

데센

DECENE

하는 일

되기(점도)를 맞춤
다른 성분을 녹이는 바탕

정의

이 원료는 다음의 구조를 갖는 탄화수소이다.

출처: 식약처 화장품 원료성분

미국 FDA 물질 등록 · UNII 7O4U4C718P · 등록명 1-Decene · 단일 화학물질

출처: 미국 FDA 물질 식별번호(UNII)

다른 언어 정의 1개

1-decene is an alkene that is decane containing one double bond at position 1. It has a role as a metabolite.

출처: PubChem

화장품에서 하는 역할

되기(점도)를 맞춤VISCOSITY CONTROLLING다른 성분을 녹이는 바탕SOLVENT

안전·규제 요약

국내 유독물 GHS 분류 없음 · 기존화학물질

출처: 한국환경공단 유독물 GHS 정보

Other restriction: ban substances that deplete the ozone layer

출처: EU CosIng 성분 목록

자세한 자료 — 표시명·식별번호·물성·시험 기록·문헌

별칭·식별 정보

DECENEINCI데센식약처 표준명1-Decene동의어

CAS No.화학물질 등록번호: 872-05-9
EC No.EU 화학물질 목록번호: 212-819-2
DTXSID미국 환경청(EPA) 화학물질 번호: DTXSID8027329
DTXCID미국 환경청(EPA) 화합물 번호: DTXCID507329

IUPAC: Dec-1-ene
분자식: C10H20
분자량: 140.27 g/mol

측정된 물성

성상: 액체
색상: 흐릿한 색상
냄새: 기분좋은 냄새
냄새역치: 7 ppm
녹는점/어는점: -66.3 ℃
초기 끓는점과 끓는점 범위: 170.5 ℃
인화점: &amp, lt, 55 ℃
인화 또는 폭발 범위의 상한/하한: 5.4 / 0.5 %
증기압: 1.67 ㎜Hg
용해도: 0.00057 g/100㎖
증기밀도: 4.84
비중: 0.7408
n-옥탄올/물분배계수 (Kow): 5.7
자연발화온도: 235 ℃
점도: 0.75 cP (at 20 ℃)
분자량: 140.266

물질 자체를 측정한 값입니다. 안전보건공단 자료는 MSDS 작성·검토 참고용이며, 원료 상품의 규격은 아닙니다.

출처: 안전보건공단 물질안전보건자료 조회 서비스

제품이 실제로 쓴 용도

미국 EPA에 이 성분을 신고한 제품 13건의 용도입니다. 화장품 밖의 제품도 포함되어 있어, 위쪽 몇 줄이 이 성분의 주된 쓰임으로 읽힌다는 뜻입니다.

중간체3
점도 조절2
윤활제2
연료2
용제2
단량체2

출처: 미국 EPA CompTox

자극·감작 시험 기록

피부 시험 19건 · 눈 시험 7건이 기록되어 있습니다.

자극 높음으로 분류5건중간으로 분류3건낮음으로 분류31건

시험마다 결론이 갈립니다(가장 많은 결론의 비중 13%). 이 성분이 자극적이라고 단정할 수 없다는 뜻입니다. 원료 자체를 시험한 기록이고, 완제품에 든 농도에서의 자극성과는 다릅니다.

시험 26건 전부 보기

Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation)
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation)
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: Magnusson and Kligman
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: U.S. EPA FIFRA (Pesticide Assessment Guidelines Subdivision F/TSCA (798.4470) according to OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to
Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act (FHSLA) according to
Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substance Labelling Act (FHSLA) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) OPPTS 870.2500 according to
Category 6.3A (Category 2)
Skin Irritation · Read Across
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to other guideline: 16 CFR 1500.41 according to
Category 2
Skin Irritation · Screening
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Register 28 (110), 6.6.1963. paragraph 191.12 Test for eye irritants. according to
Not classified
Eye Irritation · Screening
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to